Physician

Amit Navinchandra Amin, M.D.

According to 2025 Medicare claims, Amit Amin, M.D. (NPI: 1144458027) practices interventional cardiology in the Lafayette, LA market, with the plurality of this provider's patient population coming from Lafayette, LA. This provider's primary affiliated billing organization is CARDIOVASCULAR INSTITUTE OF THE SOUTH, LLC (NPI: 1982689113; TIN: 720993441) and primary practice location at 70506-5939. Amin is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535) and Ochsner Senior Care Network, LLC (ACO ID: A5662), participating under the MSSP model.

Amin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 889 traditional Medicare patients, billed 5,813 HCPCS/CPT codes, and received $657,102 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 9,024 prescription claims across 832 beneficiaries totaling $1,269,206 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 12 claims. Open Payments data shows 76 records totaling $4,157. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $10,659 to $1,269,206. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,167 to $13,387.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	120	172	$15,488
2018	2,303	8,362	$613,552
2019	2,197	9,642	$855,517
2020	1,845	7,653	$655,605
2021	1,422	7,665	$725,501
2022	775	7,819	$774,580
2023	733	7,364	$679,294
2024	889	5,813	$657,102

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	40	282	$10,659
2016	34	194	$8,938
2017	14	64	$3,158
2018	163	972	$74,401
2019	362	2,938	$242,173
2020	469	4,733	$427,533
2021	637	6,205	$690,628
2022	781	8,429	$1,040,907
2023	845	9,735	$1,263,056
2024	832	9,024	$1,269,206

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	24	$1,167
2017	N/R	24	$1,040
2018	N/R	17	$453
2019	N/R	23	$546
2020	27	27	$19,265
2021	N/R	12	$429
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	234	235	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	324	502	$88
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	367	557	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	318	349	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	160	185	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	424	18,905	$361,283
Entresto	Sacubitril/Valsartan	274	12,287	$272,650
Xarelto	Rivaroxaban	246	11,681	$214,820
Repatha Sureclick	Evolocumab	117	5,126	$98,557
Farxiga	Dapagliflozin Propanediol	90	3,544	$68,008

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	75	$4,157	Bard Peripheral Vascular, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$49,500	Cardio Flow, Inc.

Explore More Providers

FAQ

What Medicare data is available for Amit Navinchandra Amin, M.D.?

Tedicare shows public-source Medicare data for Amit Navinchandra Amin, M.D. (NPI 1144458027), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amit Navinchandra Amin, M.D. have ACO affiliation data?

Amit Navinchandra Amin, M.D. is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535) and Ochsner Senior Care Network, LLC (MSSP, ACO ID A5662).

What billing organization is linked to Amit Navinchandra Amin, M.D.?

Amit Navinchandra Amin, M.D. is linked to CARDIOVASCULAR INSTITUTE OF THE SOUTH, LLC (billing NPI 1982689113) in the available physician profile data.

Does Amit Navinchandra Amin, M.D. have Open Payments data?

Amit Navinchandra Amin, M.D. has 76 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.